Dynavax Technologies
DVAX
#4950
Rank
A$2.57 B
Marketcap
A$21.95
Share price
0.00%
Change (1 day)
4.18%
Change (1 year)

P/E ratio for Dynavax Technologies (DVAX)

P/E ratio as of February 2026 (TTM): -48.4

According to Dynavax Technologies 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -48.4375. At the end of 2024 the company had a P/E ratio of 60.8.

P/E ratio history for Dynavax Technologies from 2004 to 2025

PE ratio at the end of each year

Year P/E ratio Change
202460.8
20224.61-80.03%
202123.1-504.3%
2020-5.71120.43%
2019-2.59-27.87%
2018-3.59-64.69%
2017-10.2648.72%
2016-1.36-81.52%
2015-7.3450.27%
2014-4.89
2012-6.95

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Pfizer
PFE
20.0-141.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
26.5-154.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
17.8-136.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
22.7-146.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
17.0-135.17%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
38.8-180.10%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
15.8-132.54%๐Ÿ‡ฌ๐Ÿ‡ง UK
Agenus
AGEN
-1.04-97.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
27.3-156.44%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.